$LUNG Pulmonx Corp Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Pulmonx Corp.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Pulmonx Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in Pulmonx Corp for free.

CIK Number: 0001127537
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: LUNG
Company Address: 700 CHESAPEAKE DRIVE REDWOOD CITY 94063
Phone number: 650-364-0400
Former name: PULMONX, date of change: 2000-10-31

Pulmonx Corp. engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It carries out its operations in the following geographical locations: Europe, Middle East and Africa (EMEA), Asia Pacific, Other International and United States. The firm offers the Zephyr Endobronchial Valve, an implantable device used to occlude all airways feeding the hyperinflated lobe of a lung that is most diseased with emphysema. It also offers StratX Lung Analysis, a platform designed to treat severe emphysema and the Chartis Assessment System, a pulmonary assessment system. The company was founded by Rodney C. Perkins in December 1995 and is headquartered in Redwood City, CA.

Pulmonx Corp Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 28 2021LUNGPulmonx CorpFlorin Daniel PDirectorBuyP44.122,22298,0355,0322.8 K to 5 K (+79.07 %)
May 21 2021LUNGPulmonx CorpFrench Glendon E. IIIPresident and CEOSellS40.751,00040,75026,57127.6 K to 26.6 K (-3.63 %)
May 21 2021LUNGPulmonx CorpFrench Glendon E. IIIPresident and CEOSellS42.1919,941841,3111,199,8841.2 M to 1.2 M (-1.63 %)
May 21 2021LUNGPulmonx CorpFrench Glendon E. IIIPresident and CEOSellS41.015,059207,4701,219,8251.2 M to 1.2 M (-0.41 %)
May 11 2021LUNGPulmonx CorpRose Geoffrey BeranChief Commercial Of ...SellS42.51143116,673116.7 K to 116.7 K (0.00 %)
May 11 2021LUNGPulmonx CorpRose Geoffrey BeranChief Commercial Of ...SellS42.251184,986116,674116.8 K to 116.7 K (-0.10 %)
May 11 2021LUNGPulmonx CorpRose Geoffrey BeranChief Commercial Of ...SellS41.4790037,323116,792117.7 K to 116.8 K (-0.76 %)
May 11 2021LUNGPulmonx CorpRose Geoffrey BeranChief Commercial Of ...SellS40.473,778152,896117,692121.5 K to 117.7 K (-3.11 %)
Apr 21 2021LUNGPulmonx CorpRose Geoffrey BeranChief Commercial Of ...SellS43.244,797207,422121,470126.3 K to 121.5 K (-3.80 %)
Apr 16 2021LUNGPulmonx CorpFrench Glendon E. IIIPresident and CEOSellS43.701,00043,70027,57128.6 K to 27.6 K (-3.50 %)
Apr 16 2021LUNGPulmonx CorpFrench Glendon E. IIIPresident and CEOSellS44.215,011221,5361,224,8841.2 M to 1.2 M (-0.41 %)
Apr 16 2021LUNGPulmonx CorpFrench Glendon E. IIIPresident and CEOSellS43.6419,989872,3201,229,8951.2 M to 1.2 M (-1.60 %)
Apr 08 2021LUNGPulmonx CorpBOSTON SCIENTIFIC CORP10% OwnerSellS43.60650,00028,340,0003,988,1064.6 M to 4 M (-14.01 %)
Apr 06 2021LUNGPulmonx CorpRose Geoffrey BeranChief Commercial Of ...SellS48.4626612,890109,064109.3 K to 109.1 K (-0.24 %)
Apr 06 2021LUNGPulmonx CorpRose Geoffrey BeranChief Commercial Of ...SellS47.594,531215,630109,330113.9 K to 109.3 K (-3.98 %)

View all Pulmonx Corp insider transactions.